Latest Sprint Bioscience News & Updates

See the latest news and media coverage for Sprint Bioscience. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Sprint Bioscience

Pharmaceutical company developing oncology drug candidates

sprintbioscience.com
Headquarters
Huddinge, Sweden
Founded year
2009
Company type
Public company
Number of employees
40–50

Last updated

Latest news about Sprint Bioscience

In short: Sprint Bioscience sold its TREX1 program to Gilead for up to $400 million and advanced its oncology and CKD pipelines during early 2026.

Company announcements

Sprint Bioscience

Sprint Bioscience calls an annual general meeting

The annual general meeting is held on 13 May 2026 in Huddinge. The nomination committee proposes board election and remuneration. The board proposes no dividend and authorization to issue shares.

Unlock all announcements with a

Media coverage

Yahoo Finance

Gilead snaps up Sprint’s TREX1 immunotherapy programme for $400m

Gilead Sciences has secured the rights to Sprint Bioscience’s preclinical oncology programme for up ...

Unlock all articles with a

Never miss news about Sprint Bioscience

Track Sprint Bioscience and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sprint Bioscience competitors & trending companies

Browse news for competitors to Sprint Bioscience and other trending companies.